AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2015

Jun 26, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2015-06-23

Reporting Person: Biller Scott (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-23	Stock option (right to buy)	$0.4675	A	12363	Acquired	2020-12-06	Common stock (12363)	Direct

Footnotes

F1: This option was granted on December 7, 2010. The shares underlying this option vested as to 25% of the shares upon the achievement of a performance milestone, and as to the remaining 75% in 36 equal monthly installments thereafter. The performance criteria was met on June 23, 2015, resulting in the vesting of the otpions as to 3,091 shares.